Post-approval studies (Phase 4)Study completedNCT02681991
What this trial is testing
Phase Ⅳ Clinical Trial to Evaluate of Renamezin in Patients With Chronic Renal Failure.
Who this might be right for
Chronic Renal Failure
Daewon Pharmaceutical Co., Ltd. 110